ERBITUX CETUXIMAB Injection, 200 mg/100 mL (2 mg/mL), 100 mL per single-use vial, Rx only, Manufactured by: ImClone LLC, a wholly-owned subsidiary of Eli Lilly and Company, Branchburg, NJ 08876 USA. NDC: 66733-958-23
Published November 21, 2018 · Recall initiated: November 8, 2018
Summary
FDA records drug Class III recall D-0248-2019, published November 21, 2018 and initiated November 8, 2018. Recalling firm: Eli Lilly & Co; Status: Terminated; Reported quantity: 9,380 vials; Lot: Lot number: C1700167, exp 9/2020. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Labeling: Missing label; potential for missing primary container label on the vial.
What to do
Voluntary: Firm initiated · Letter
Get an email if ERBITUX has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- ERBITUX
- Manufacturer
- Eli Lilly & Co
- Distributor
- AL, AZ, CA, KS, LA, MS, OH, OR, TN, TX and Puerto Rico
- Lot
- Lot number: C1700167, exp 9/2020
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAZero Xtreme Dietary Supplement 30-count capsules. By:Zero Xtreme Registro Sanitario No SD2014-0002208 LLC-USANovember 21, 2018
- FDANitrofurantoin Capsules, USP (Monohydrate/Macrocrystals) 100 mg, packaged in a) 100-capsule bottles (NDCNovember 21, 2018
- FDAMetoprolol Tartrate Injection, USP 5mg/5mL, vials, Rx only, MFG: Claris Lifesciences Inc., North Brunswick, NJNovember 21, 2018
- FDAIsosorbide Dinitrate Tablets, USP 10 mg,100-count bottles, Rx Only Manufactured by: Sandoz Inc., Princeton, NJNovember 21, 2018
- FDATadalafil SR 12 mg Capsules packed in 8,13, 20, 30, 40 or 60 dram screw top pill bottle, Carie Boyd'sNovember 21, 2018
- FDAIsosorbide Dinitrate Tablets, USP 20 mg,100-count bottles, Rx Only Manufactured by: Sandoz Inc., Princeton, NJNovember 21, 2018
Questions about this recall
Was ERBITUX CETUXIMAB Injection, 200 mg/100 mL (2 mg/mL), 100 mL per single-use vial, Rx only, Manufactured by: ImClone LLC, a wholly-owned subsidiary of Eli Lilly and Company, Branchburg, NJ 08876 USA. NDC: 66733-958-23 recalled?
Yes. FDA published recall D-0248-2019 on November 21, 2018. Reported hazard: Labeling: Missing label; potential for missing primary container label on the vial.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: ERBITUX.